DXPE vs TECH · P/E 18, rev $1.80B vs P/E 65, rev $1.22B
DXP Enterprises Inc (DXPE) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
DXP Enterprises Inc (DXPE) is a industrial distribution company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported DXPE revenue for 2024-12-31 was $1.80B. Net income was $70.5M. Revenue was up 7.4% from 2023-12-31 to 2024-12-31. DXPE currently screens at market cap $1.38B and trailing P/E 18.3.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
DXPE currently screens at market cap $1.38B and trailing P/E 18.3. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the DXPE and TECH stock pages for the full models.
Not investment advice.